n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide and Schizophrenia

n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide has been researched along with Schizophrenia in 1 studies

*Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergh, CL; Duncan, JN; Harris, DW; Huff, RM; Lahti, RA; Lawson, CF; Lutzke, BS; Martin, IJ; Rees, SA; Schlachter, SK; Sih, JC; Smith, MW; TenBrink, RE	1

Other Studies

1 other study(ies) available for n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide and Schizophrenia

Article	Year
(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist. Journal of medicinal chemistry, 1996, Jun-21, Volume: 39, Issue:13 Topics: Animals; Antipsychotic Agents; Biological Availability; CHO Cells; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Humans; Molecular Structure; Piperazines; Protein Binding; Quinpirole; Receptors, Adrenergic; Receptors, Dopamine D4; Receptors, Serotonin; Schizophrenia; Sulfonamides	1996

Article

Year

(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.

Journal of medicinal chemistry, 1996, Jun-21, Volume: 39, Issue:13

Topics: Animals; Antipsychotic Agents; Biological Availability; CHO Cells; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Humans; Molecular Structure; Piperazines; Protein Binding; Quinpirole; Receptors, Adrenergic; Receptors, Dopamine D4; Receptors, Serotonin; Schizophrenia; Sulfonamides

1996